Skip to content

Our GMP-ready pharmaceutical 3D printers have patent-protected in-built quality control and exchangeable printhead systems for technology versatility, quality assurance and easy cleaning. We also provide advanced control software, formulation development services and consultation with our world leading scientists for all of your pharmaceutical 3D printing needs.

FABRX carried out the world’s first clinical study for 3D printed personalised medicine in 2018 and launched their first printer, the M3DIMAKER 1 in 2020. They have since launched their 3-printhead M3DIMAKER 2 pharmaceutical 3D printer and are involved in several more clinical studies worldwide. FABRX collaborates with universities, pharmacies, hospitals and pharmaceutical companies around the world to make this exciting new technology a reality, developing new pharma-inks (preprinted formulation) for personalised medicine and implementing 3D printing into clinical trial work flows for improved efficiency. Get in touch now!

For more informatin, please visit: https://www.fabrx.co.uk

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.